arrow
S

Sally Dunaway Young

stanford university school of medicine
H指数:36
被引数:5,245

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validity of insole-derived spatiotemporal and center-of-pressure metrics in ambulatory Duchenne muscular dystrophy and spinal muscular atrophy

足底压力垫衍生的时空和压力中心指标在 Duchenne 肌营养不良和脊髓性肌萎缩症患者行走中的有效性

2026-09-210
OAAI
Navigating new motor function trajectories: Consensus recommendations for assessment in the era of newborn screening and early treatment in SMA

导航新的运动功能轨迹:在脊髓性肌萎缩症新生儿筛查和早期治疗时代评估的共识建议

2026-04-070
PRE
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy

SAPPHIRE临床试验的简明语言摘要,该试验研究apitegromab在儿童和年轻成人脊髓性肌萎缩症患者中的应用。

2025-11-130
OAAI
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial

阿皮特格罗玛ab在非行走型2型或3型脊髓性肌萎缩症中的安全性与有效性(SAPPHIRE研究):一项III期、双盲、随机、安慰剂对照试验

2025-08-130
PRE
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Apitegromab在2型和3型脊髓性肌萎缩症患者中的安全性和有效性

2024-03-126
OAAI
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3

未经治疗的2型和3型脊髓性肌萎缩症患者队列中修订的Hammersmith量表中的疾病轨迹

2024-02-275
OAAI
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)

评估辅助的六分钟循环测试,以衡量非卧床患者的耐力脊髓性肌萎缩症 (SMA)

2023-12-081
OAAI
Nusinersen Treatment of Children with Later-Onset Spinal Muscular Atrophy and Scoliosis Is Associated with Improvements or Stabilization of Motor Function

Nusinersen治疗晚发性脊髓性肌萎缩症和脊柱侧凸的儿童与运动功能的改善或稳定有关

2023-07-268
OAAI
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants

未经治疗的儿科2型和3型SMA参与者的大型队列中修订的Hammersmith量表评分的2年变化

2023-02-287
OAAI
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
2021-12-0114
OAAI